-
脓毒症是感染引起的机体反应失衡,继而导致的危及生命的多器官功能障碍[1]。脓毒症是对人类生命健康的威胁,是全球范围内感染致死的主要原因[2]。随着人口老龄化日益严重、多重耐药菌不断出现,脓毒症的发病率居高不下[3-4],并以每年1.5%~13%的速率增长[5]。近年来新型冠状病毒肺炎在全球肆虐,研究发现病毒性脓毒症是新冠肺炎患者死亡的主要原因[6],这进一步提升了我们对脓毒症的认识。中医药在新冠肺炎患者治疗过程中发挥了重要作用,使我们对中医药治疗脓毒症的优势和重要性有了新的认识[7]。中医没有对应脓毒症的概念,因此,根据不同的症状将脓毒症归为中医的温病、温毒和伤寒证型。本文针对脓毒症的病因病机和治疗方法两大方面对中医药治疗脓毒症的研究现状进行综述。
Research progress of anti-sepsis treatment using traditional Chinese medicine
-
摘要: 脓毒症病机复杂,危及生命,是医学领域的一大难题,临床上多以抗生素、激素、机械通气等治疗为主,缺乏特异性治疗药物,治疗效果欠佳。近年来中医药治疗脓毒症取得了越来越多的进展,本文综述了脓毒症的病因病机和治疗策略,重点阐释了清热解毒、通里攻下、活血化瘀、扶正固本四种疗法,探讨了中医药疗法治疗脓毒症的优势和不足,以期为临床脓毒症的治疗提供参考。Abstract: Sepsis is life-threatening with complex pathogenesis. It is a big problem in the medical field. Clinically, antibiotics, hormones and mechanical ventilation are the main treatments. There is a lack of specific therapeutic drugs. The treatment effect is not good. In recent years, more and more progress has been made in the treatment of sepsis with traditional Chinese medicine. This article reviews the etiology, pathogenesis and treatment strategies of sepsis. It focuses on four therapies, including clearing away heat and detoxification, clearing the interior, activating blood circulation and removing blood stasis, and strengthening the foundation. We further discuss the advantages and disadvantages of traditional Chinese medicine in the treatment of sepsis, in order to provide reference for the clinical treatment of sepsis.
-
Key words:
- sepsis /
- pathogenesis /
- traditional Chinese medicine /
- therapy
-
[1] SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3)[J]. JAMA,2016,315(8):801-810. doi: 10.1001/jama.2016.0287 [2] GIBSON B, TERBLANCHE C. Anaesthetic management of patients with severe Sepsis[J]. Br J Anaesth, 2011, 106(3): 416-417;authorreply417. [3] VINCENT J L, MARSHALL J C, NAMENDYS-SILVA S A, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit[J]. Lancet Respir Med,2014,2(5):380-386. doi: 10.1016/S2213-2600(14)70061-X [4] BURTON J, SINGER M. Sepsis and septic shock[M]//Perioperative Medicine. Amsterdam: Elsevier, 2022: 564-575. [5] LEWIS J M, ABOUYANNIS M, KATHA G, et al. Population incidence and mortality of Sepsis in an urban African setting, 2013-2016[J]. Clin Infect Dis,2020,71(10):2547-2552. doi: 10.1093/cid/ciz1119 [6] LI H, LIU L, ZHANG D Y, et al. SARS-CoV-2 and viral Sepsis: observations and hypotheses[J]. Lancet,2020,395(10235):1517-1520. doi: 10.1016/S0140-6736(20)30920-X [7] 智屹惠, 王坤根, 王灵聪. 《中国严重脓毒症/脓毒性休克治疗指南(2014)》中医药部分解读[J]. 中华危重病急救医学, 2015(6):429-434. doi: 10.3760/cma.j.issn.2095-4352.2015.06.003 [8] 赵红芳, 江其敏. 刘清泉教授应用中医药治疗脓毒症的临床经验[J]. 中国中医急症, 2017, 26(9):1563-1565. doi: 10.3969/j.issn.1004-745X.2017.09.018 [9] 崔应珉 王淼注译. 黄帝内经素问[M]. 郑州: 中州古籍出版社, 2010. [10] 王旨引, 刘俊杰, 杨双杰, 等. 探析“毒”与慢性心力衰竭的关系[J]. 中医学报, 2021, 36(6):1143-1146. doi: 10.16368/j.issn.1674-8999.2021.06.241 [11] 刘清泉. 对脓毒症中医病机特点及治法的认识[J]. 北京中医, 2007, 26(4):198-200. doi: 10.3969/j.issn.1674-1307.2007.04.003 [12] 李志军, 李银平. 从“卫气营血”辨证到“三证三法”看脓毒症的诊治思辨[J]. 中华危重病急救医学, 2019, 31(2):135-138. [13] 金芳芳, 蔡永敏. 热邪、温邪考辨[J]. 中医学报, 2021, 36(9):1838-1841. doi: 10.16368/j.issn.1674-8999.2021.09.385 [14] 杨李旺, 杨蓉, 赵焕新, 等. 黄连解毒汤通过诱导自噬减轻脓毒症小鼠肝损伤[J]. 中国实验方剂学杂志, 2022, 28(5):71-76. [15] 张仕娜, 郑爱华, 刘红梅. 大柴胡汤对热毒内结型脓毒症患者外周血炎症因子含量的影响[J]. 亚太传统医药, 2020, 16(7):150-152. [16] 李明雁, 沈云霞, 万青, 等. 子午流注择时应用清瘟败毒饮合凉膈散加减通腑治疗脓毒症胃肠功能障碍(热毒炽盛证)的临床研究[J]. 中国中医急症, 2020, 29(8):1407-1410. doi: 10.3969/j.issn.1004-745X.2020.08.025 [17] 梁志奇, 吴晖, 叶妍婕, 等. 犀角地黄汤对脓毒症凝血功能障碍患者凝血指标和临床疗效的影响[J]. 当代医学, 2021, 27(25):136-137. doi: 10.3969/j.issn.1009-4393.2021.25.057 [18] 王慧慧. 脓毒症胃肠功能障碍中医用药规律探讨[D]. 济南: 山东中医药大学, 2015. [19] FAY K T, FORD M L, COOPERSMITH C M. The intestinal microenvironment in Sepsis[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(10 Pt B): 2574-2583. [20] 夏露露, 吴晋兰. “有胃气则生, 无胃气则死”[J]. 实用中医内科杂志, 2013, 27(10):34-35. [21] 周雯, 万建国, 邬叔兵, 等. 大黄治疗脓毒症急性胃肠损伤的临床研究[J]. 江西医药, 2021, 56(2):156-158. doi: 10.3969/j.issn.1006-2238.2021.02.010 [22] SHANG L R, LIU Y H, LI J X, et al. Emodin protects Sepsis associated damage to the intestinal mucosal barrier through the VDR/Nrf2/HO-1 pathway[J]. Front Pharmacol,2021,12:724511. doi: 10.3389/fphar.2021.724511 [23] 贾合磊, 卢长青, 袁彬, 等. 大黄提取物对脓毒症大鼠急性肾损伤的保护作用和对Keap1/Nrf2信号通路的影响[J]. 药物分析杂志, 2021, 41(6):979-985. doi: 10.16155/j.0254-1793.2021.06.06 [24] 陈敏, 王倩. 大承气汤联合西医常规治疗干预脓毒症伴急性胃肠损伤的临床研究[J]. 上海中医药大学学报, 2022, 36(S1):20-22,102. [25] 谭鑫, 吴康. 复方大承气汤联合乌司他丁治疗重症监护室脓毒症伴肠功能障碍的临床观察[J]. 中国民间疗法, 2020, 28(14):76-78. doi: 10.19621/j.cnki.11-3555/r.2020.1437 [26] 徐洁如, 来志超. 大黄附子汤治疗脓毒症伴胃肠功能紊乱临床研究[J]. 新中医, 2021, 53(4):29-32. doi: 10.13457/j.cnki.jncm.2021.04.007 [27] 杨洁, 胡云霞, 白宇. 脓毒症中“瘀热”病机探析[J]. 中国中医急症, 2016, 25(5):939-940. doi: 10.3969/j.issn.1004-745X.2016.05.062 [28] 阮怀文, 郭氏清水, 孟静岩. 浅议《沈菊人医案》“气为血帅”理论的运用[J]. 天津中医药, 2019, 36(6):615-616. [29] 任超, 姚人骐, 王丽雪, 等. 血必净注射液及其组分羟基红花黄色素A对脓毒症大鼠凝血功能和生存率影响的比较研究[J]. 中华危重病急救医学, 2021(10):1198-1202. doi: 10.3760/cma.j.cn121430-20210225-00291 [30] WANG Y P, GUO Y, WEN P S, et al. Three ingredients of safflower alleviate acute lung injury and inhibit NET release induced by lipopolysaccharide[J]. Mediators Inflamm,2020,2020:2720369. [31] WANG X T, PENG Z, AN Y Y, et al. Paeoniflorin and hydroxysafflor yellow A in xuebijing injection attenuate Sepsis-induced cardiac dysfunction and inhibit proinflammatory cytokine production[J]. Front Pharmacol,2020,11:614024. [32] 李兵, 段宝民, 乔永红, 等. 丹参多酚酸盐对严重脓毒症/脓毒症休克凝血功能的影响[J]. 河南大学学报(医学版), 2014, 33(3):201-203. doi: 10.15991/j.cnki.41-1361/r.2014.03.023 [33] MEI L Y, HE M H, ZHANG C Y, et al. Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p[J]. Sci Rep,2019,9(1):19370. doi: 10.1038/s41598-019-55980-4 [34] 宋立人. 现代中药学大辞典[Z]. 北京: 人民卫生出版社, 2001. [35] 吴峥嵘, 李渊, 郝素英. 参附注射液对脓毒症模型小鼠脾脏淋巴细胞Treg/Th17免疫平衡的影响[J]. 中医学报, 2021, 36(12):2648-2653. doi: 10.16368/j.issn.1674-8999.2021.12.547 [36] 刘子璇, 刘文丽, 郝浩, 等. 参附注射液对脓毒症大鼠肺损伤的保护作用[J]. 中国中医急症, 2022, 31(2):218-221,232. doi: 10.3969/j.issn.1004-745X.2022.02.007 [37] 何涛涛, 曹樟全, 张洪波. 生脉注射液联合超声指导下液体复苏治疗脓毒性休克临床研究[J]. 新中医, 2021, 53(20):74-78. doi: 10.13457/j.cnki.jncm.2021.20.019 [38] 张振波, 徐秋萍. 人参皂苷Rg1联合抗生素治疗小鼠脓毒症急性肺损伤[J]. 四川大学学报(医学版), 2020, 51(3):371-375. [39] 黄敏, 陶星宇, 贾宝辉, 等. 人参皂苷Rb1调控内质网应激对脓毒症小鼠重要脏器的保护作用[J]. 中国医药导报, 2019, 16(30):17-20,25.
计量
- 文章访问数: 5664
- HTML全文浏览量: 3940
- PDF下载量: 35
- 被引次数: 0